Glonoinum 6 X Globules ; Granules ; Liquid is a Health Canada–registered human drug (DIN 02234518) held by Dolisos Canada Inc., containing Nitroglycerin. Health Canada lists its status as Cancelled Post Market (status date 24 Apr 2006). Nexara Health has matched 148 registrations of Nitroglycerin across 4 other regulated markets.
Health Canada registration
| DIN | 02234518 |
|---|---|
| Brand name | Glonoinum |
| Active ingredient | Nitroglycerin |
| Strength | 6 X |
| Dosage form | Globules ; Granules ; Liquid |
| Route | Oral |
| Company | Dolisos Canada Inc. |
| Status | Cancelled Post Market — 24 Apr 2006 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Nitroglycerin registered in other markets
148 registrations of the same molecule in 4 national registries outside Canada (first 28 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Romania | NITROGLICERINA 0,5 mg | — | 0,5mg | Compr. Subling. | P6L | ANMDMR nomenclator |
| Romania | NITROMINT 0,4 mg/doza | — | 0,4mg/doza | Spray Sublingual | P6L | ANMDMR nomenclator |
| Romania | NITROMINT 2,6 mg | — | 2,6mg | Compr. Cu Elib. Prel. | P6L | ANMDMR nomenclator |
| Romania | NITRONAL 1 mg/ml | — | 1mg/ml | Sol. Perf. | PR | ANMDMR nomenclator |
| Romania | NITRONAL 1 mg/ml | — | 1mg/ml | Sol. Perf. | PR | ANMDMR nomenclator |
| Romania | NITRONAL 1 mg/ml | — | 1mg/ml | Sol. Perf. | PR | ANMDMR nomenclator |
| Saudi Arabia | Netrosan | — | 0.4 | Inactive | SFDA | |
| Saudi Arabia | Nitroderm Tts 5 Patches | — | 25 | Inactive | SFDA | |
| Saudi Arabia | Nitroderm Tts 5 Patches | — | 25 | Inactive | SFDA | |
| Saudi Arabia | Nitroderm Tts-10 System | — | 50 | Inactive | SFDA | |
| Saudi Arabia | Nitroderm Tts-10 System | — | 50 | Inactive | SFDA | |
| Saudi Arabia | Retrosin Ointment | — | 0.4 | Inactive | SFDA | |
| Taiwan | Goyceryl Trinitrate For Injection "Dbl" | David Bull Laboratories | 注射劑 | 已註銷 | TFDA | |
| Taiwan | Mifiry Injection | 杏林新生製藥股份有限公司 | 注射劑 | Registered | TFDA | |
| Taiwan | Millisrol Injection | Takasaki Plant, Nippon Kayaku Co., Ltd. | 注射劑 | Registered | TFDA | |
| Taiwan | Minitran Transdermal Delivery System 0.2mg/Hr | 3m Pharmaceuticals | 穿皮貼片劑 | 已註銷 | TFDA | |
| Taiwan | Minitran Transdermal Delivery System 0.4mg/Hr | 3m Pharmaceuticals | 穿皮貼片劑 | 已註銷 | TFDA | |
| Taiwan | N.T.G. Premixed Injection 0.2mg/ml | 台裕化學製藥廠股份有限公司 | 注射劑 | Registered | TFDA | |
| Taiwan | N.T.G. Premixed Injection 0.4mg/mL | 台裕化學製藥廠股份有限公司 | 注射劑 | Registered | TFDA | |
| Taiwan | Nitro Retard Capsules "Mack" | Heinrich Mack Nachf. GmbH & Co. | 持續性藥效膠囊劑 | 已註銷 | TFDA | |
| United States | Glonoinum | Boiron | Pellet | listed | FDA NDC | |
| United States | Glonoinum | Boiron | Pellet | listed | FDA NDC | |
| United States | Glonoinum | Boiron | Pellet | listed | FDA NDC | |
| United States | Glonoinum | Boiron | Pellet | listed | FDA NDC | |
| United States | Glonoinum | Boiron | Pellet | listed | FDA NDC | |
| United States | Glonoinum | Boiron | Pellet | listed | FDA NDC | |
| United States | Glonoinum | Boiron | Pellet | listed | FDA NDC | |
| United States | Glonoinum | Boiron | Pellet | listed | FDA NDC |
See every manufacturer of Nitroglycerin worldwide →
Regulator price references for Nitroglycerin
Published list or reimbursement prices for Nitroglycerin presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Saudi Arabia | Nitroderm Tts 5 Patches | 17.60 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Nitroderm Tts-10 System | 33.75 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Nitroderm Tts 5 Patches | 58.30 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Nitroderm Tts-10 System | 62.60 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Netrosan | 76.45 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Retrosin Ointment | 91.40 SAR | public | SFDA | 2026-09-01 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Glonoinum (DIN 02234518) marketed in Canada?
No. Health Canada lists DIN 02234518 as Cancelled Post Market as of 24 Apr 2006.
Who holds the Canadian licence for this product?
Dolisos Canada Inc. is the company of record in the Health Canada Drug Product Database.
Is Nitroglycerin registered outside Canada?
Yes — Nexara Health has matched 148 registrations in 4 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02234518, status date 2006-04-24; national medicine registries: ANMDMR nomenclator, FDA NDC, SFDA, TFDA; price sources: SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02234518, status date 2006-04-24; national medicine registries: ANMDMR nomenclator, FDA NDC, SFDA, TFDA; price sources: SFDA.
Health Canada Drug Product Database (DPD), DIN 02234518, status date 2006-04-24; national medicine registries: ANMDMR nomenclator, FDA NDC, SFDA, TFDA; price sources: SFDA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.